A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet

patent: 1 patent

Citations

dimensions_citation: 92 Dimensions

Readers on

mendeley: 93 Mendeley

Summary News Patents Dimensions citations

So far, Altmetric has seen 1 news story.

A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer

Oncology Nurse Advisor , 02 May 2016

May 02, 2016 the ONA take: Approximately 246 660 patients are expected to receive a diagnosis of breast cancer in the United…